The dipeptidyl peptidase-4 (DPP-4) inhibitor vildagliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis. [electronic resource]
Producer: 20120605Description: 979-87 p. digitalISSN:- 1348-4540
- Adamantane -- analogs & derivatives
- Aged
- Blood Glucose -- metabolism
- Diabetes Mellitus, Type 2 -- blood
- Dipeptidyl-Peptidase IV Inhibitors -- therapeutic use
- Female
- Glycated Hemoglobin -- metabolism
- Humans
- Male
- Middle Aged
- Nitriles -- therapeutic use
- Prospective Studies
- Pyrrolidines -- therapeutic use
- Renal Dialysis -- methods
- Statistics, Nonparametric
- Vildagliptin
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.